数据之源，洞见之始

GPCR ligand binding

Montezano AC, Kuriakose J, Hood KY, Sin YY, Camargo LL, Namkung Y, Castro CH, Santos RA, Alves-Lopes R, Tejeda G, Passaglia P, Basheer S, Gallen E, Findlay JE, Awan FR, Laporte SA, MacLean MR, Baillie GS, Touyz RM. Ang-(1-7) and ET-1 Interplay Through Mas and ETB Receptor Interaction Defines a Novel Vasoprotective Mechanism. Hypertension. 2025 Feb;82(2):267–81. doi: 10.1161/hypertensionaha.124.22693. PMID: 39633565.; Wang C, Liu Y, Lanier M, Yeager A, Singh I, Gumpper RH, Krumm BE, DeLeon C, Zhang S, Boehm M, Pittner R, Baron A, Dvorak L, Bacon C, Shoichet BK, Martinborough E, Fay JF, Cao C, Roth BL. High-affinity agonists reveal recognition motifs for the MRGPRD GPCR. Cell Reports. 2024 Dec;43(12):114942. doi: 10.1016/j.celrep.2024.114942.; Rukavina Mikusic NL, Silva MG, Erra Díaz FA, Pineda AM, Ferragut F, Gómez KA, Mazzitelli L, Gonzalez Maglio DH, Nuñez M, Santos RAS, Grecco HE, Gironacci MM. Alamandine, a protective component of the renin-angiotensin system, reduces cellular proliferation and interleukin-6 secretion in human macrophages through MasR-MrgDR heteromerization. Biochem Pharmacol. 2024 Nov;229():116480. doi: 10.1016/j.bcp.2024.116480. PMID: 39128587.; Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM. Alternative Renin-Angiotensin System. Hypertension. 2024 May;81(5):964–76. doi: 10.1161/hypertensionaha.123.21364.; Proença AB, Medeiros GR, Reis GDS, Losito LDF, Ferraz LM, Bargut TCL, Soares NP, Alexandre-Santos B, Campagnole-Santos MJ, Magliano DC, Nobrega ACLD, Santos RAS, Frantz EDC. Adipose tissue plasticity mediated by the counterregulatory axis of the renin-angiotensin system: Role of Mas and MrgD receptors. J Cell Physiol. 2024 Jun;239(6):e31265. doi: 10.1002/jcp.31265. PMID: 38577921.; Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A. Structural insight into the activation mechanism of MrgD with heterotrimeric Gi-protein revealed by cryo-EM. Communications Biology. 2022 Jul 15;5(1):707. doi: 10.1038/s42003-022-03668-3.; Zheng W, Wang Z, Jiang X, Zhao Q, Shen J. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives. J Med Chem. 2020 Dec 24;63(24):15153–86. doi: 10.1021/acs.jmedchem.0c01093. PMID: 33314936.; Kappes L, Amer RL, Sommerlatte S, Bashir G, Plattfaut C, Gieseler F, Gemoll T, Busch H, Altahrawi A, Al-Sbiei A, Haneefa SM, Arafat K, Schimke LF, Khawanky NE, Schulze-Forster K, Heidecke H, Kerstein-Staehle A, Marschner G, Pitann S, Ochs HD, Mueller A, Attoub S, Fernandez-Cabezudo MJ, Riemekasten G, al-Ramadi BK, Cabral-Marques O. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis. Scientific Reports. 2020 Sep 28;10(1):15931. doi: 10.1038/s41598-020-72960-1.; Franco I, Hoebeke P, Baka-Ostrowska M, Bolong D, Davies LN, Dahler E, Snijder R, Stroosma O, Verheggen F, Newgreen D, Bosman B, Vande Walle J. Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies. J Pediatr Urol. 2020 Apr;16(2):180.e1–8. doi: 10.1016/j.jpurol.2019.12.012. PMID: 32007426.; Fein MN, Fischer DA, O’Keefe AW, Sussman GL. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy, Asthma & Clinical Immunology. 2019 Oct 01;15(1):61. doi: 10.1186/s13223-019-0375-9.; Moehle MS, Conn PJ. Roles of the M₄ acetylcholine receptor in the basal ganglia and the treatment of movement disorders. Movement Disorders. 2019 Jun 18;34(8):1089–99. doi: 10.1002/mds.27740.; Ztaou S, Amalric M. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease. Neurochem Int. 2019 Jun;126():1–10. doi: 10.1016/j.neuint.2019.02.019. PMID: 30825602.; Amato D, Kruyer A, Samaha AN, Heinz A. Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. Front Psychiatry. 2019;10():314. PMID: 31214054; PMCID: PMC6557273.; Kim SH, Riaposova L, Ahmed H, Pohl O, Chollet A, Gotteland J, Hanyaloglu A, Bennett PR, Terzidou V. Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2a-induced Contractions and Inflammatory Responses in Human Myometrium. Scientific Reports. 2019 Apr 08;9(1):5792. doi: 10.1038/s41598-019-42181-2.; Burghi V, Echeverría EB, Sosa MH, Quiroga DT, Muñoz MC, Davio C, Monczor F, Fernández NC, Dominici FP. Participation of Gai-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways. Front. Pharmacol. 2019 Feb 22;10(). doi: 10.3389/fphar.2019.00146.; Wu M, Liang Y, Dai Z, Wang S. Perioperative dexmedetomidine reduces delirium after cardiac surgery: A meta-analysis of randomized controlled trials. Journal of Clinical Anesthesia. 2018 Nov;50():33–42. doi: 10.1016/j.jclinane.2018.06.045.; Flükiger J, Hollinger A, Speich B, Meier V, Tontsch J, Zehnder T, Siegemund M. Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis. Annals of Intensive Care. 2018 Sep 20;8(1):92. doi: 10.1186/s13613-018-0437-z.; Poch E, Rodas L, Blasco M, Molina A, Quintana L. An update on tolvaptan for autosomal dominant polycystic kidney disease. Drugs Today (Barc). 2018 Sep;54(9):519–33. doi: 10.1358/dot.2018.54.9.2776624. PMID: 30303493.; Osland ST, Steeves TD, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev. 2018 Jun 26;6():CD007990. PMID: 29944175; PMCID: PMC6513283.; Tran HDM, Tran YH, Tran TD, Jong M, Coroneo M, Sankaridurg P. A Review of Myopia Control with Atropine. Journal of Ocular Pharmacology and Therapeutics. 2018 Jun;34(5):374–9. doi: 10.1089/jop.2017.0144.; Yoshida M, Kakizaki H, Takahashi S, Nagai S, Kurose T. Long-term safety and efficacy of the novel ß ₃ -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. Int J of Urology. 2018 May 11;25(7):668–75. doi: 10.1111/iju.13596.; Yoshida M, Takeda M, Gotoh M, Nagai S, Kurose T. Vibegron, a Novel Potent and Selective ß3-Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study. Eur Urol. 2018 May;73(5):783–90. doi: 10.1016/j.eururo.2017.12.022. PMID: 29366513.; Gómez-Aguayo F, Paczka JA, Leñero-Córdova R, Jiménez-Román J, Davila-Villarreal J, Hartleben C, Baiza-Durán L, Olvera-Montaño O, García-Velez F, Muñoz-Villegas P. A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma. Ophthalmology and Therapy. 2018 Apr 21;7(1):145–56. doi: 10.1007/s40123-018-0128-8.; Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7). Physiological Reviews. 2018 Jan 01;98(1):505–53. doi: 10.1152/physrev.00023.2016.; Dubin A, Lattanzio B, Gatti L. The spectrum of cardiovascular effects of dobutamine - from healthy subjects to septic shock patients. Rev Bras Ter Intensiva. 2017 Oct;29(4):490–8. PMID: 29340539; PMCID: PMC5764562.; Beier J, Fuhr R, Seoane B, Massana E, de Miquel G, Pujol H, Ruiz S. Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study. Pharmacology Res & Perspec. 2017 Sep 27;5(5). doi: 10.1002/prp2.356.; Gold LS, Papp K, Lynde C, Lain E, Gooderham M, Johnson S, Kerrouche N. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study. J Drugs Dermatol. 2017 Sep 01;16(9):909–16. PMID: 28915286.; Kim M, Kim J, Jeong S, Jo H, Woo YR, Park HJ. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel. Experimental Dermatology. 2017 Aug 15;26(11):1143–5. doi: 10.1111/exd.13381.; Keeshin BR, Ding Q, Presson AP, Berkowitz SJ, Strawn JR. Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review. Neurology and Therapy. 2017 Jul 28;6(2):247–57. doi: 10.1007/s40120-017-0078-4.; Nguyen V, Tiemann D, Park E, Salehi A. Alpha-2 Agonists. Anesthesiol Clin. 2017 Jun;35(2):233–45. doi: 10.1016/j.anclin.2017.01.009. PMID: 28526145.; Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. Journal of the Neurological Sciences. 2017 May;376():129–32. doi: 10.1016/j.jns.2017.03.025.; Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM. Novel selective ß ₁ -adrenoceptor antagonists for concomitant cardiovascular and respiratory disease. The FASEB Journal. 2017 Apr 11;31(7):3150–66. doi: 10.1096/fj.201601305r.; Di Salvo J, Nagabukuro H, Wickham LA, Abbadie C, DeMartino JA, Fitzmaurice A, Gichuru L, Kulick A, Donnelly MJ, Jochnowitz N, Hurley AL, Pereira A, Sanfiz A, Veronin G, Villa K, Woods J, Zamlynny B, Zycband E, Salituro GM, Frenkl T, Weber AE, Edmondson SD, Struthers M. Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder. The Journal of Pharmacology and Experimental Therapeutics. 2017 Feb;360(2):346–55. doi: 10.1124/jpet.116.237313.; Noronha Neto C C, Maia SSB, Katz L, Coutinho IC, Souza AR, Amorim MM. Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial. PLoS ONE. 2017 Jan 26;12(1):e0168124. doi: 10.1371/journal.pone.0168124.; Vijayakumar D, Wijemanne S, Jankovic J. Treatment of blepharospasm with apraclonidine. Journal of the Neurological Sciences. 2017 Jan;372():57–9. doi: 10.1016/j.jns.2016.11.029.; Wangler NJ, Jayaraman S, Zhu R, Mechref Y, Abbruscato TJ, Bickel U, Karamyan VT. Preparation and preliminary characterization of recombinant neurolysin for in vivo studies. J Biotechnol. 2016 Sep 20;234():105–15. doi: 10.1016/j.jbiotec.2016.07.007. PMID: 27496565.; Bajracharya SR, Prasad PN, Ghimire R. Management of Organophosphorus Poisoning. J Nepal Health Res Counc. 2016 Sep;14(34):131–8. PMID: 28327676.; Beier J, Pujol H, Seoane B, Jimenez E, Astbury C, Massana E, Ruiz S, de Miquel G. Abediterol, a novel long-acting ß2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD. BMC Pulmonary Medicine. 2016 Jul 20;16(1):102. doi: 10.1186/s12890-016-0266-5.; Alamo C, López-Muñoz F, Sánchez-García J. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd). Actas Esp Psiquiatr. 2016 May;44(3):107–12. PMID: 27254403.; Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Endothelin. Pharmacological Reviews. 2016 Apr;68(2):357–418. doi: 10.1124/pr.115.011833.; Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE. Discovery of Vibegron: A Potent and Selective ß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. J Med Chem. 2016 Jan 28;59(2):609–23. doi: 10.1021/acs.jmedchem.5b01372. PMID: 26709102.; Kauh CY, Bursztyn LL. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage. J Neuroophthalmol. 2015 Sep;35(3):287–8. doi: 10.1097/wno.0000000000000222. PMID: 25768246.; Gelotte CK, Zimmerman BA. Pharmacokinetics, Safety, and Cardiovascular Tolerability of Phenylephrine HCl 10, 20, and 30 mg After a Single Oral Administration in Healthy Volunteers. Clinical Drug Investigation. 2015 Aug 13;35(9):547–58. doi: 10.1007/s40261-015-0311-9.; Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacological Reviews. 2015 Jul;67(3):601–55. doi: 10.1124/pr.114.010249.; Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol. 2015 Feb;28(1):83–8. doi: 10.1097/wco.0000000000000163. PMID: 25502048.; William Tank A, Lee Wong D. Peripheral and Central Effects of Circulating Catecholamines. Comprehensive Physiology. 2015 Jan;5(1):1–15. doi: 10.1002/j.2040-4603.2015.tb00599.x.; Cernecka H, Sand C, Michel MC: The odd sibling: features of beta3-adrenoceptor pharmacology. Mol Pharmacol. 2014 Nov;86(5):479-84. doi: 10.1124/mol.114.092817. Epub 2014 Jun 2.; Currigan DA, Hughes RJ, Wright CE, Angus JA, Soeding PF. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. Anesthesiology. 2014 Nov;121(5):930–6. doi: 10.1097/aln.0000000000000430. PMID: 25198173.; Mathur RP, Nayak S, Sivaramakrishnan R, Jain V. Role of Alpha Blockers in Hypertension with Benign Prostatic Hyperplasia. J Assoc Physicians India. 2014 Sep;62(9 Suppl):40–4. PMID: 26245042.; Ahn LY, Kim SE, Yi S, Dingemanse J, Lim KS, Jang I, Yu K. Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects. American Journal of Cardiovascular Drugs. 2014 Jun 07;14(5):377–85. doi: 10.1007/s40256-014-0081-4.; Liamis G, Filippatos TD, Elisaf MS. Treatment of hyponatremia: the role of lixivaptan. Expert Review of Clinical Pharmacology. 2014 Apr 28;7(4):431–41. doi: 10.1586/17512433.2014.911085.; Nadeau G, Schröder A, Moore K, Genois L, Lamontagne P, Hamel M, Pellerin E, Bolduc S. Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study. Can Urol Assoc J. 2014 Mar;8(3-4):118–23. PMID: 24839481; PMCID: PMC4001633.; Ortega VE. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. Clin Genet. 2014 Jul;86(1):12–20. doi: 10.1111/cge.12377. PMID: 24641588.; Alagha K, Palot A, Sofalvi T, Pahus L, Gouitaa M, Tummino C, Martinez S, Charpin D, Bourdin A, Chanez P. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Therapeutic Advances in Chronic Disease. 2014 Jan 06;5(2):85–98. doi: 10.1177/2040622313518227.; Checler F. Experimental stroke: neurolysin back on stage. Journal of Neurochemistry. 2014 Jan 05;129(1):1–3. doi: 10.1111/jnc.12635.; Rashid M, Wangler NJ, Yang L, Shah K, Arumugam TV, Abbruscato TJ, Karamyan VT. Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain. Journal of Neurochemistry. 2013 Nov 19;129(1):179–89. doi: 10.1111/jnc.12513.; Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding CL, Lecomte JM, Schwartz JC; HARMONY I study group. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 2013 Nov;12(11):1068–75. doi: 10.1016/s1474-4422(13)70225-4. PMID: 24107292.; Ishizuka T, Yoshigae Y, Murayama N, Izumi T. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1. Drug Metab Dispos. 2013 Nov;41(11):1888–95. doi: 10.1124/dmd.113.053595. PMID: 23946449.; Yoshiki H, Uwada J, Umada H, Kobayashi T, Takahashi T, Yamakawa T, Yamaguchi A, Yokoyama O, Muramatsu I. Agonist pharmacology at recombinant a_1A- and a_1L-adrenoceptors and in lower urinary tract a₁-adrenoceptors. British J Pharmacology. 2013 Oct 28;170(6):1242–52. doi: 10.1111/bph.12403.; Gialama F, Maniadakis N. Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan. Vasc Health Risk Manag. 2013;9():575–92. PMID: 24124375; PMCID: PMC3794869.; Andersson K, Martin N, Nitti V. Selective ß ₃ -Adrenoceptor Agonists for the Treatment of Overactive Bladder. Journal of Urology. 2013 Oct;190(4):1173–80. doi: 10.1016/j.juro.2013.02.104.; Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013 May 31;(5):CD002095. PMID: 23728637; PMCID: PMC7066537.; Nitti VW, Khullar V, Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013 May 21;67(7):619–32. doi: 10.1111/ijcp.12194.; Meyer RC, Giddens MM, Schaefer SA, Hall RA. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A. 2013 Jun 04;110(23):9529–34. PMID: 23690594; PMCID: PMC3677493.; Lautner RQ, Villela DC, Fraga-Silva RA, Silva N, Verano-Braga T, Costa-Fraga F, Jankowski J, Jankowski V, Sousa F, Alzamora A, Soares E, Barbosa C, Kjeldsen F, Oliveira A, Braga J, Savergnini S, Maia G, Peluso AB, Passos-Silva D, Ferreira A, Alves F, Martins A, Raizada M, Paula R, Motta-Santos D, Klempin F, Kemplin F, Pimenta A, Alenina N, Sinisterra R, Bader M, Campagnole-Santos MJ, Santos RA. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res. 2013 Apr 12;112(8):1104–11. doi: 10.1161/circresaha.113.301077. PMID: 23446738.; Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, Mozaffar T: A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Crit Rev Phys Rehabil Med. 2013;25(1-2):11-22. doi: 10.1615/CritRevPhysRehabilMed.2013007945.; Graham GJ, Locati M. Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6. The Journal of Pathology. 2012 Dec 12;229(2):168–75. doi: 10.1002/path.4123.; Aparici M, Gómez-Angelats M, Vilella D, Otal R, Carcasona C, Viñals M, Ramos I, Gavaldà A, De Alba J, Gras J, Cortijo J, Morcillo E, Puig C, Ryder H, Beleta J, Miralpeix M. Pharmacological Characterization of Abediterol, a Novel Inhaled ß2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models. The Journal of Pharmacology and Experimental Therapeutics. 2012 Aug;342(2):497–509. doi: 10.1124/jpet.112.193284.; Yanai K, Rogala B, Chugh K, Paraskakis E, Pampura AN, Boev R. Safety considerations in the management of allergic diseases: focus on antihistamines. Current Medical Research and Opinion. 2012 Mar 29;28(4):623–42. doi: 10.1185/03007995.2012.672405.; Gras J. Mirabegron for the treatment of overactive bladder. Drugs Today (Barc). 2012 Jan;48(1):25–32. doi: 10.1358/dot.2012.48.1.1738056. PMID: 22384458.; Harvey RD. Muscarinic receptor agonists and antagonists: effects on cardiovascular function. Handb Exp Pharmacol. 2012;(208):299–316. doi: 10.1007/978-3-642-23274-9_13. PMID: 22222704.; Ehlert FJ, Pak KJ, Griffin MT. Muscarinic agonists and antagonists: effects on gastrointestinal function. Handb Exp Pharmacol. 2012;(208):343–74. doi: 10.1007/978-3-642-23274-9_15. PMID: 22222706.; Boyd KN, Mailman RB. Dopamine receptor signaling and current and future antipsychotic drugs. Handb Exp Pharmacol. 2012;(212):53–86. PMID: 23129328; PMCID: PMC4711768.; Jensen BC, O'Connell TD, Simpson PC. Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure. Journal of Molecular and Cellular Cardiology. 2011 Oct;51(4):518–28. doi: 10.1016/j.yjmcc.2010.11.014.; Gomez R, Por ED, Berg KA, Clarke WP, Glucksman MJ, Jeske NA. Metallopeptidase inhibition potentiates bradykinin-induced hyperalgesia. Pain. 2011 Jul;152(7):1548–54. PMID: 21458920; PMCID: PMC3114295.; Zhenfeng Zheng, Huilan Shi, Junya Jia, Dong Li, Shan Lin. A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension. J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):365–74. doi: 10.1177/1470320310391503. PMID: 21421652.; Cambron M, Maertens H, Crevits L. Apraclonidine and my pupil. Clinical Autonomic Research. 2011 Mar 08;21(5):347–51. doi: 10.1007/s10286-011-0118-6.; Bhadada SV, Patel BM, Mehta AA, Goyal RK. ß₃Receptors: role in cardiometabolic disorders. Therapeutic Advances in Endocrinology. 2011 Feb 18;2(2):65–79. doi: 10.1177/2042018810390259.; Abraham WT, Aranda JM, Boehmer JP, Elkayam U, Gilbert EM, Gottlieb SS, Hasenfuß G, Kukin M, Lowes BD, O’Connell JB, Tavazzi L, Feldman AM, Ticho B, Orlandi C. Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study. Clinical Translational Sci. 2010 Oct;3(5):249–53. doi: 10.1111/j.1752-8062.2010.00217.x.; Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010 Nov;65(11):956–62. doi: 10.1136/thx.2009.128082. PMID: 20871122.; Kong RCK, Shilling PJ, Lobb DK, Gooley PR, Bathgate RAD. Membrane receptors: Structure and function of the relaxin family peptide receptors. Molecular and Cellular Endocrinology. 2010 May;320(1-2):1–15. doi: 10.1016/j.mce.2010.02.003.; Sanu O, Lamont RF. Critical appraisal and clinical utility of atosiban in the management of preterm labor. Ther Clin Risk Manag. 2010 Apr 26;6():191–9. PMID: 20463780; PMCID: PMC2861440.; Seeman P. Dopamine D2 Receptors as Treatment Targets in Schizophrenia. Clinical Schizophrenia & Related Psychoses. 2010 Apr;4(1):56–73. doi: 10.3371/csrp.4.1.5.; Stahl SM. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms. J Clin Psychiatry. 2010 Mar;71(3):223–4. doi: 10.4088/jcp.09bs05899pur. PMID: 20331927.; Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology. 2010 Mar 10;129(4):536–46. doi: 10.1111/j.1365-2567.2009.03209.x.; Schemann M, Hafsi N, Michel K, Kober OI, Wollmann J, Li Q, Zeller F, Langer R, Lee K, Cellek S. The beta3-adrenoceptor agonist GW427353 (Solabegron) decreases excitability of human enteric neurons via release of somatostatin. Gastroenterology. 2010 Jan;138(1):266–74. doi: 10.1053/j.gastro.2009.09.046. PMID: 19786030.; Nijmeijer S, Leurs R, Vischer HF. Constitutive activity of the histamine H(1) receptor. Methods Enzymol. 2010;484():127–47. doi: 10.1016/b978-0-12-381298-8.00007-1. PMID: 21036230.; Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet. 2009 Nov 28;374(9704):1840–8. doi: 10.1016/s0140-6736(09)61913-9. PMID: 19922995.; Jensen BC, Swigart PM, De Marco T, Hoopes C, Simpson PC: {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail. 2009 Nov;2(6):654-63. doi: 10.1161/CIRCHEARTFAILURE.108.846212. Epub 2009 Aug 6.; Van Lith LH, Oosterom J, Van Elsas A, Zaman GJ. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. J Biomol Screen. 2009 Oct;14(9):1067–75. doi: 10.1177/1087057109341407. PMID: 19641221.; Jensen BC, Swigart PM, Laden M, DeMarco T, Hoopes C, Simpson PC. The Alpha-1D Is the Predominant Alpha-1-Adrenergic Receptor Subtype in Human Epicardial Coronary Arteries. Journal of the American College of Cardiology. 2009 Sep;54(13):1137–45. doi: 10.1016/j.jacc.2009.05.056.; Klos A, Tenner AJ, Johswich K, Ager RR, Reis ES, Köhl J. The role of the anaphylatoxins in health and disease. Molecular Immunology. 2009 Sep;46(14):2753–66. doi: 10.1016/j.molimm.2009.04.027.; Peng Q, Li K, Sacks SH, Zhou W. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets. 2009 Jul;8(3):236–46. doi: 10.2174/187152809788681038. PMID: 19601884.; Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009 Jan 03;373(9657):31–41. doi: 10.1016/s0140-6736(08)61764-x. PMID: 19058842.; Sears MR, Ottosson A, Radner F, Suissa S. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J. 2009 Jan;33(1):21–32. doi: 10.1183/09031936.00145006. PMID: 18768573.; Bonham C, Abbott C. Are second generation antipsychotics a distinct class? J Psychiatr Pract. 2008 Jul;14(4):225–31. PMID: 18664891; PMCID: PMC3632396.; Ginès P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D; HypoCAT Study Investigators. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008 Jul;48(1):204–13. doi: 10.1002/hep.22293. PMID: 18508290.; Fahed S, Grum DF, Papadimos TJ. Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety. Patient Safety in Surgery. 2008 May 27;2(1):13. doi: 10.1186/1754-9493-2-13.; Baker JG. A study of antagonist affinities for the human histamine H₂receptor. British J Pharmacology. 2008 Mar;153(5):1011–21. doi: 10.1038/sj.bjp.0707644.; Kamen L, Henney HR, Runyan JD. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Current Medical Research and Opinion. 2007 Dec 31;24(2):425–39. doi: 10.1185/030079908x261113.; Torricelli M, Giovannelli A, Leucci E, Florio P, De Falco G, Torres PB, Reis FM, Leoncini L, Petraglia F. Placental neurokinin B mRNA expression increases at preterm labor. Placenta. 2007 Oct;28(10):1020–3. doi: 10.1016/j.placenta.2007.04.006. PMID: 17561251.; de Boer RA, Voors AA, van Veldhuisen DJ. Nebivolol: third-generation beta-blockade. Expert Opin Pharmacother. 2007 Jul;8(10):1539–50. doi: 10.1517/14656566.8.10.1539. PMID: 17661735.; Quaranta L, Turano R, Pizzolante T. Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension. Clin Ophthalmol. 2007 Jun;1(2):93–7. PMID: 19668496; PMCID: PMC2704505.; Perez DM. Structure-function of alpha1-adrenergic receptors. Biochem Pharmacol. 2007 Apr 15;73(8):1051–62. PMID: 17052695; PMCID: PMC2034198.; Halls ML, van der Westhuizen ET, Bathgate RAD, Summers RJ. Relaxin Family Peptide Receptors – former orphans reunite with their parent ligands to activate multiple signalling pathways. British J Pharmacology. 2007 Mar;150(6):677–91. doi: 10.1038/sj.bjp.0707140.; Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A. Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma. Eur Respir J. 2007 May;29(5):871–8. doi: 10.1183/09031936.00060006. PMID: 17251236.; Okamura N, Reinscheid RK. Neuropeptide S: a novel modulator of stress and arousal. Stress. 2007 Aug;10(3):221–6. doi: 10.1080/10253890701248673. PMID: 17613937.; Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007 Jan;49(1):185–92. doi: 10.1161/01.hyp.0000251865.35728.2f. PMID: 17116756.; Ligneau X, Perrin D, Landais L, Camelin J-, Calmels TPG, Berrebi-Bertrand I, Lecomte J-, Parmentier R, Anaclet C, Lin J-, Bertaina-Anglade V, la Rochelle CD, d’Aniello F, Rouleau A, Gbahou F, Arrang J-, Ganellin CR, Stark H, Schunack W, Schwartz J-. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology. The Journal of Pharmacology and Experimental Therapeutics. 2007 Jan;320(1):365–75. doi: 10.1124/jpet.106.111039.; Johswich K, Martin M, Thalmann J, Rheinheimer C, Monk PN, Klos A. Ligand Specificity of the Anaphylatoxin C5L2 Receptor and Its Regulation on Myeloid and Epithelial Cell Lines. Journal of Biological Chemistry. 2006 Dec;281(51):39088–95. doi: 10.1074/jbc.m609734200.; Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 2006 Dec;17(6):501–19. doi: 10.1016/j.cytogfr.2006.09.009. PMID: 17084101.; Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C; SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006 Nov 16;355(20):2099–112. doi: 10.1056/nejmoa065181. PMID: 17105757.; Soupart A, Gross P, Legros JJ, Alföldi S, Annane D, Heshmati HM, Decaux G. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol. 2006 Nov;1(6):1154–60. doi: 10.2215/cjn.00160106. PMID: 17699341.; Rozec B, Gauthier C. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther. 2006 Sep;111(3):652–73. doi: 10.1016/j.pharmthera.2005.12.002. PMID: 16480771.; Comerford I, Milasta S, Morrow V, Milligan G, Nibbs R. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur J Immunol. 2006 Jul;36(7):1904–16. doi: 10.1002/eji.200535716. PMID: 16791897.; Canals M, Jenkins L, Kellett E, Milligan G. Up-regulation of the Angiotensin II Type 1 Receptor by the MAS Proto-oncogene Is Due to Constitutive Activation of Gq/G11 by MAS. Journal of Biological Chemistry. 2006 Jun;281(24):16757–67. doi: 10.1074/jbc.m601121200.; Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006 Jun;69(12):2124–30. doi: 10.1038/sj.ki.5000432. PMID: 16672911.; Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y. A Novel, Selective, and Orally Available Antagonist for CC Chemokine Receptor 3. The Journal of Pharmacology and Experimental Therapeutics. 2006 Apr;317(1):244–50. doi: 10.1124/jpet.105.097048.; Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol. 2006 Feb 15;176(4):2197–207. doi: 10.4049/jimmunol.176.4.2197. PMID: 16455976.; Takai T, Takaya T, Nakano M, Akutsu H, Nakagawa A, Aimoto S, Nagai K, Ikegami T. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor. Journal of Peptide Science. 2006 Jan 23;12(7):443–54. doi: 10.1002/psc.747.; Slusarz MJ, Slusarz R, Ciarkowski J. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system. Biopolymers. 2006 Apr 05;81(5):321–38. doi: 10.1002/bip.20420. PMID: 16333859.; Balabanian K, Lagane B, Infantino S, Chow KYC, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F. The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes. Journal of Biological Chemistry. 2005 Oct;280(42):35760–6. doi: 10.1074/jbc.m508234200.; Clader JW, Wang Y. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Curr Pharm Des. 2005;11(26):3353–61. doi: 10.2174/138161205774370762. PMID: 16250841.; Vendelin J, Pulkkinen V, Rehn M, Pirskanen A, Räisänen-Sokolowski A, Laitinen A, Laitinen LA, Kere J, Laitinen T. Characterization of GPRA, a novel G protein-coupled receptor related to asthma. Am J Respir Cell Mol Biol. 2005 Sep;33(3):262–70. doi: 10.1165/rcmb.2004-0405oc. PMID: 15947423.; Postma DS, Koppelman GH. Confirmation of GPRA: a putative drug target for asthma. Am J Respir Crit Care Med. 2005 Jun 15;171(12):1323–4. doi: 10.1164/rccm.2503006. PMID: 15941840.; Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005 Feb;146(2):624–32. doi: 10.1210/en.2004-1064. PMID: 15539556.; Baker JG. The selectivity of ß-adrenoceptor antagonists at the human ß1, ß2 and ß3 adrenoceptors. British J Pharmacology. 2005 Feb;144(3):317–22. doi: 10.1038/sj.bjp.0706048.; Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, Nepomuceno D, Kamme F, Tran D, Zhu J, Wilkinson T, Bathgate R, Eriste E, Sillard R, Lovenberg TW. INSL5 Is a High Affinity Specific Agonist for GPCR142 (GPR100). Journal of Biological Chemistry. 2005 Jan;280(1):292–300. doi: 10.1074/jbc.m409916200.; Migeotte I, Riboldi E, Franssen JD, Grégoire F, Loison C, Wittamer V, Detheux M, Robberecht P, Costagliola S, Vassart G, Sozzani S, Parmentier M, Communi D. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med. 2005 Jan 03;201(1):83–93. PMID: 15623572; PMCID: PMC2212760.; Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM, Grantham JJ. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004 Sep;66(3):964–73. doi: 10.1111/j.1523-1755.2004.00843.x. PMID: 15327388.; Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. 2004 Dec;30(12):2188–96. doi: 10.1007/s00134-004-2417-z. PMID: 15338124.; Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 2004 Aug 19;43(4):487–97. doi: 10.1016/j.neuron.2004.08.005. PMID: 15312648.; Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther. 2004 Jul;103(1):21–80. doi: 10.1016/j.pharmthera.2004.05.002. PMID: 15251227.; Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol. 2004 Jun 01;172(11):7078–85. doi: 10.4049/jimmunol.172.11.7078. PMID: 15153530.; Bolli MH, Marfurt J, Grisostomi C, Boss C, Binkert C, Hess P, Treiber A, Thorin E, Morrison K, Buchmann S, Bur D, Ramuz H, Clozel M, Fischli W, Weller T. Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists. J Med Chem. 2004 May 20;47(11):2776–95. doi: 10.1021/jm031115r. PMID: 15139756.; Bonecchi R, Locati M, Galliera E, Vulcano M, Sironi M, Fra AM, Gobbi M, Vecchi A, Sozzani S, Haribabu B, Van Damme J, Mantovani A. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol. 2004 Apr 15;172(8):4972–6. doi: 10.4049/jimmunol.172.8.4972. PMID: 15067078.; De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood. 2004 Apr 01;103(7):2452–9. doi: 10.1182/blood-2003-08-2857. PMID: 14525775.; Gupte J, Cutler G, Chen JL, Tian H. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1508–13. PMID: 14757815; PMCID: PMC341764.; Zanchetti A. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients. Blood Press Suppl. 2004 Oct;1():17–32. doi: 10.1080/08038020410016548. PMID: 15587108.; Elagoz A, Henderson D, Babu PS, Salter S, Grahames C, Bowers L, Roy M, Laplante P, Grazzini E, Ahmad S, Lembo PMC. A truncated form of CKß8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. British J Pharmacology. 2004 Jan;141(1):37–46. doi: 10.1038/sj.bjp.0705592.; Stroe AF, Gheorghiade M. Carvedilol: beta-blockade and beyond. Rev Cardiovasc Med. 2004;5 Suppl 1():S18–27. PMID: 15184840.; Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R, Lovenberg TW. Identification of Relaxin-3/INSL7 as a Ligand for GPCR142. Journal of Biological Chemistry. 2003 Dec;278(50):50765–70. doi: 10.1074/jbc.m308996200.; Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R, Lovenberg TW. Identification of Relaxin-3/INSL7 as an Endogenous Ligand for the Orphan G-protein-coupled Receptor GPCR135. Journal of Biological Chemistry. 2003 Dec;278(50):50754–64. doi: 10.1074/jbc.m308995200.; Ruilope LM, Segura J. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clin Ther. 2003 Dec;25(12):3044–64. doi: 10.1016/s0149-2918(03)90091-9. PMID: 14749145.; Sugo T, Murakami Y, Shimomura Y, Harada M, Abe M, Ishibashi Y, Kitada C, Miyajima N, Suzuki N, Mori M, Fujino M. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochemical and Biophysical Research Communications. 2003 Oct;310(3):860–8. doi: 10.1016/j.bbrc.2003.09.102.; Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003 Oct 23;349(17):1614–27. doi: 10.1056/nejmoa035322. PMID: 14573733.; Tournamille C, Filipe A, Wasniowska K, Gane P, Lisowska E, Cartron JP, Colin Y, Le Van Kim C. Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites. Br J Haematol. 2003 Sep;122(6):1014–23. doi: 10.1046/j.1365-2141.2003.04533.x. PMID: 12956774.; Jiang Y, Luo L, Gustafson EL, Yadav D, Laverty M, Murgolo N, Vassileva G, Zeng M, Laz TM, Behan J, Qiu P, Wang L, Wang S, Bayne M, Greene J, Monsma F, Zhang FL. Identification and Characterization of a Novel RF-amide Peptide Ligand for Orphan G-protein-coupled Receptor SP9155. Journal of Biological Chemistry. 2003 Jul;278(30):27652–7. doi: 10.1074/jbc.m302945200.; Xanthou G, Duchesnes CE, Williams TJ, Pease JE. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol. 2003 Aug;33(8):2241–50. doi: 10.1002/eji.200323787. PMID: 12884299.; Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003 Jul 08;100(14):8258–63. PMID: 12829792; PMCID: PMC166216.; Nuttall SL, Routledge HC, Kendall MJ. A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther. 2003 Jun;28(3):179–86. doi: 10.1046/j.1365-2710.2003.00477.x. PMID: 12795776.; Cao L, Weil MH, Sun S, Tang W. Vasopressor agents for cardiopulmonary resuscitation. J Cardiovasc Pharmacol Ther. 2003 Jun;8(2):115–21. doi: 10.1177/107424840300800204. PMID: 12808484.; Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003 Jun;63(6):1256–72. doi: 10.1124/mol.63.6.1256. PMID: 12761335.; Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG, Lerner MR, King DS, O'Dowd BF, Sakurai T, Yanagisawa M. Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc. Natl. Acad. Sci. U.S.A. 2003 Apr 28;100(10):6251–6. doi: 10.1073/pnas.0837789100.; Mzhavia N, Pan H, Che FY, Fricker LD, Devi LA. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J Biol Chem. 2003 Apr 25;278(17):14704–11. PMID: 12560336; PMCID: PMC3862352.; Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein. Journal of Biological Chemistry. 2003 Mar;278(13):11123–9. doi: 10.1074/jbc.m206169200.; Lüttichau HR, Clark-Lewis I, Jensen PØ, Moser C, Gerstoft J, Schwartz TW. A Highly Selective CCR2 Chemokine Agonist Encoded by Human Herpesvirus 6. Journal of Biological Chemistry. 2003 Mar;278(13):10928–33. doi: 10.1074/jbc.m211329200.; Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RAD, Hsueh AJW. H3 Relaxin Is a Specific Ligand for LGR7 and Activates the Receptor by Interacting with Both the Ectodomain and the Exoloop 2. Journal of Biological Chemistry. 2003 Mar;278(10):7855–62. doi: 10.1074/jbc.m212457200.; Fra AM, Locati M, Otero K, Sironi M, Signorelli P, Massardi ML, Gobbi M, Vecchi A, Sozzani S, Mantovani A. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol. 2003 Mar 01;170(5):2279–82. doi: 10.4049/jimmunol.170.5.2279. PMID: 12594248.; Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K. Molecular cloning and characterization of prokineticin receptors. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 2002 Dec;1579(2-3):173–9. doi: 10.1016/s0167-4781(02)00546-8.; Derick S, Cheng LL, Voirol MJ, Stoev S, Giacomini M, Wo NC, Szeto HH, Ben Mimoun M, Andres M, Gaillard RC, Guillon G, Manning M. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors. Endocrinology. 2002 Dec;143(12):4655–64. doi: 10.1210/en.2002-220363. PMID: 12446593.; Gether U, Asmar F, Meinild AK, Rasmussen SG. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol. 2002 Dec;91(6):304–12. doi: 10.1034/j.1600-0773.2002.910607.x. PMID: 12688373.; Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med. 2002 Nov;8(11):1296–302. PMID: 12368905; PMCID: PMC2777269.; Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J. The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem. 2002 Oct 04;277(40):37647–54. doi: 10.1074/jbc.m203907200. PMID: 12149255.; Shrimpton CN, Smith AI, Lew RA. Soluble metalloendopeptidases and neuroendocrine signaling. Endocr Rev. 2002 Oct;23(5):647–64. doi: 10.1210/er.2001-0032. PMID: 12372844.; Dutta EJ, Li JT. Beta-agonists. Med Clin North Am. 2002 Sep;86(5):991–1008. doi: 10.1016/s0025-7125(02)00031-7. PMID: 12428542.; Kumagai J, Hsu SY, Matsumi H, Roh J, Fu P, Wade JD, Bathgate RAD, Hsueh AJW. INSL3/Leydig Insulin-like Peptide Activates the LGR8 Receptor Important in Testis Descent. Journal of Biological Chemistry. 2002 Aug;277(35):31283–6. doi: 10.1074/jbc.c200398200.; Lin SL, Setya S, Johnson-Farley NN, Cowen DS. Differential coupling of 5-HT₁ receptors to G proteins of the G_i family. British J Pharmacology. 2002 Aug;136(7):1072–8. doi: 10.1038/sj.bjp.0704809.; Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry. 2002 Aug 20;41(33):10418–25. doi: 10.1021/bi026020q. PMID: 12173928.; Wenzel-Seifert K, Liu HY, Seifert R. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Biochem Pharmacol. 2002 Jul 01;64(1):9–20. doi: 10.1016/s0006-2952(02)00924-3. PMID: 12106601.; Wellendorph P, Goodman MW, Burstein ES, Nash NR, Brann MR, Weiner DM. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor. Neuropharmacology. 2002 Jun;42(7):929–40. doi: 10.1016/s0028-3908(02)00041-2. PMID: 12069903.; Tan CP, Sano H, Iwaasa H, Pan J, Sailer AW, Hreniuk DL, Feighner SD, Palyha OC, Pong SS, Figueroa DJ, Austin CP, Jiang MM, Yu H, Ito J, Ito M, Ito M, Guan XM, MacNeil DJ, Kanatani A, Van der Ploeg LH, Howard AD. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics. 2002 Jun;79(6):785–92. doi: 10.1006/geno.2002.6771. PMID: 12036292.; Jeng AY, Mulder P, Kwan AL, Battistini B. Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications. Can J Physiol Pharmacol. 2002 May;80(5):440–9. doi: 10.1139/y02-025. PMID: 12056551.; Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y, Yamada T, Hinuma S, Inatomi N, Ohtaki T, Onda H, Fujino M. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochemical and Biophysical Research Communications. 2002 Apr;293(1):396–402. doi: 10.1016/s0006-291x(02)00239-5.; Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. Journal of Human Hypertension. 2002 Apr 24;16(Suppl 2):s13–6. doi: 10.1038/sj.jhh.1001391.; Cain SA, Monk PN. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem. 2002 Mar 01;277(9):7165–9. doi: 10.1074/jbc.c100714200. PMID: 11773063.; Taylor F, Raskind MA. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol. 2002 Feb;22(1):82–5. doi: 10.1097/00004714-200202000-00013. PMID: 11799347.; Seeman P. Atypical Antipsychotics: Mechanism of Action. Can J Psychiatry. 2002 Feb;47(1):27–38. doi: 10.1177/070674370204700106.; Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ. Activation of orphan receptors by the hormone relaxin. Science. 2002 Jan 25;295(5555):671–4. doi: 10.1126/science.1065654. PMID: 11809971.; Brand S, Sakaguchi T, Gu X, Colgan SP, Reinecker HC. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology. 2002 Jan;122(1):166–77. doi: 10.1053/gast.2002.30329. PMID: 11781291.; Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001 Dec 06;345(23):1667–75. doi: 10.1056/nejmoa010713. PMID: 11759645.; Lorenzo M, Khan RY, Wang Y, Tai SC, Chan GC, Cheung AH, Marsden PA. Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 2001 Nov;1522(1):46–52. doi: 10.1016/s0167-4781(01)00283-4.; Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 08;345(19):1368–77. doi: 10.1056/nejmoa010307. PMID: 11794169.; Rodriguez M, Beauverger P, Naime I, Rique H, Ouvry C, Souchaud S, Dromaint S, Nagel N, Suply T, Audinot V, Boutin JA, Galizzi JP. Cloning and Molecular Characterization of the Novel Human Melanin-Concentrating Hormone Receptor MCH2. Molecular Pharmacology. 2001 Oct;60(4):632–9. doi: 10.1016/s0026-895x(24)12288-2.; Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden J, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M. The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54. Journal of Biological Chemistry. 2001 Sep;276(37):34631–6. doi: 10.1074/jbc.m104847200.; Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, Arkhitko O, Lewis T, Evans JF, George SR, O'Dowd BF. Discovery and mapping of ten novel G protein-coupled receptor genes. Gene. 2001 Sep 05;275(1):83–91. doi: 10.1016/s0378-1119(01)00651-5. PMID: 11574155.; Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001 May 31;411(6837):613–7. doi: 10.1038/35079135. PMID: 11385580.; Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY. Identification of Two Prokineticin cDNAs: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle. Molecular Pharmacology. 2001 Apr;59(4):692–8. doi: 10.1016/s0026-895x(24)09236-8.; Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. 2001 Apr;12(3):118–22. doi: 10.1016/s1043-2760(00)00362-3. PMID: 11306336.; Smith RG, Leonard R, Bailey AR, Palyha O, Feighner S, Tan C, Mckee KK, Pong SS, Griffin P, Howard A. Growth hormone secretagogue receptor family members and ligands. Endocrine. 2001 Feb;14(1):9–14. doi: 10.1385/endo:14:1:009. PMID: 11322507.; Unger T. Pharmacology of AT1-receptor blockers. Blood Press Suppl. 2001;(3):5–10. doi: 10.1080/08037050152518302. PMID: 11683476.; Ruilope L, Jäger B, Prichard B. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial. Blood Press. 2001;10(4):223–9. doi: 10.1080/08037050152669747. PMID: 11800061.; Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, Yonehara S. Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages. Journal of Biological Chemistry. 2000 Dec;275(52):40663–6. doi: 10.1074/jbc.c000761200.; Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular Cloning and Characterization of a New Human Histamine Receptor, HH4R. Biochemical and Biophysical Research Communications. 2000 Dec;279(2):615–20. doi: 10.1006/bbrc.2000.4008.; Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yao W, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B. Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF. Journal of Biological Chemistry. 2000 Dec;275(50):39324–31. doi: 10.1074/jbc.m004385200.; Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW, Zhou S, Kouranova EV, Nagorny R, Guevarra MS, Dai M, Lerman GS, Vaysse PJ, Branchek TA, Gerald C, Forray C, Adham N. Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System. Journal of Biological Chemistry. 2000 Oct;275(42):32452–9. doi: 10.1074/jbc.m004613200.; Langmead CJ, Szekeres PG, Chambers JK, Ratcliffe SJ, Jones DNC, Hirst WD, Price GW, Herdon HJ. Characterization of the binding of [¹²⁵I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor. British J Pharmacology. 2000 Oct;131(4):683–8. doi: 10.1038/sj.bjp.0703617.; Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol. 2000 Sep;16(9):1123–32. PMID: 11021956.; Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, Jenkins N, Copeland NG, Gilbert DJ, Nguyen N, Abrams J, Kershenovich D, Smith K, McClanahan T, Vicari AP, Zlotnik A. Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2). Journal of Biological Chemistry. 2000 Jul;275(29):22313–23. doi: 10.1074/jbc.m001461200.; Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, Manyonda IT, Lowry PJ. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000 Jun 15;405(6788):797–800. doi: 10.1038/35015579. PMID: 10866201.; Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda Si, Clouthier DE, Yanagisawa M. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest. 2000 May;105(10):1373–82. PMID: 10811845; PMCID: PMC315458.; Jarmin DI, Rits M, Bota D, Gerard NP, Graham GJ, Clark-Lewis I, Gerard C. Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. J Immunol. 2000 Apr 01;164(7):3460–4. doi: 10.4049/jimmunol.164.7.3460. PMID: 10725696.; Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Müller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, Ruzicka T, Lehmann P, Oldham E, Zlotnik A. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol. 2000 Apr 01;164(7):3465–70. doi: 10.4049/jimmunol.164.7.3465. PMID: 10725697.; Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens. 2000 Apr;14 Suppl 1():S73–86. doi: 10.1038/sj.jhh.1000991. PMID: 10854085.; Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry. 2000 Apr;157(4):514–20. doi: 10.1176/appi.ajp.157.4.514. PMID: 10739409.; Gosling J, Dairaghi DJ, Wang Y, Hanley M, Talbot D, Miao Z, Schall TJ. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol. 2000 Mar 15;164(6):2851–6. doi: 10.4049/jimmunol.164.6.2851. PMID: 10706668.; Raskind MA, Dobie DJ, Kanter ED, Petrie EC, Thompson CE, Peskind ER. The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry. 2000 Feb;61(2):129–33. doi: 10.4088/jcp.v61n0208. PMID: 10732660.; Yu CR, Peden KW, Zaitseva MB, Golding H, Farber JM. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J Immunol. 2000 Feb 01;164(3):1293–305. doi: 10.4049/jimmunol.164.3.1293. PMID: 10640743.; Bakker RA, Wieland K, Timmerman H, Leurs R. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol. 2000 Jan 03;387(1):R5–7. doi: 10.1016/s0014-2999(99)00803-1. PMID: 10633171.; Lee J, Bang E, Chae K, Kim J, Lee DW, Lee W. Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. European Journal of Biochemistry. 1999 Dec 15;266(3):831–9. doi: 10.1046/j.1432-1327.1999.00911.x.; Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999 Dec 09;402(6762):656–60. doi: 10.1038/45230. PMID: 10604470.; Isogaya M, Sugimoto Y, Tanimura R, Tanaka R, Kikkawa H, Nagao T, Kurose H. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists. Mol Pharmacol. 1999 Nov;56(5):875–85. doi: 10.1124/mol.56.5.875. PMID: 10531390.; Guthrie RM, Siegel RL. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT). Clin Ther. 1999 Oct;21(10):1732–48. doi: 10.1016/s0149-2918(99)80052-6. PMID: 10566569.; Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 1999 Sep 16;401(6750):282–6. doi: 10.1038/45809. PMID: 10499587.; Valdenaire O, Barret A, Schweizer A, Rohrbacher E, Mongiat F, Pinet F, Corvol P, Tougard C. Two di-leucine-based motifs account for the different subcellular localizations of the human endothelin-converting enzyme (ECE-1) isoforms. J Cell Sci. 1999 Sep;112 Pt 18():3115–25. doi: 10.1242/jcs.112.18.3115. PMID: 10462527.; Parker EM, Xia L. Extensive Alternative Splicing in the 5'-Untranslated Region of the Rat and Human Neuropeptide Y Y₅ Receptor Genes Regulates Receptor Expession. Journal of Neurochemistry. 1999 Sep;73(3):913–20. doi: 10.1046/j.1471-4159.1999.0730913.x.; Fujii R, Fukusumi S, Hosoya M, Kawamata Y, Habata Y, Hinuma S, Sekiguchi M, Kitada C, Kurokawa T, Nishimura O, Onda H, Sumino Y, Fujino M. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul Pept. 1999 Aug 31;83(1):1–10. doi: 10.1016/s0167-0115(99)00028-2. PMID: 10498338.; Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, Redman C. Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group Protein. 1999 Aug 15;94(4):1440–50. doi: 10.1182/blood.v94.4.1440.416k01_1440_1450.; Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem. 1999 Jul 30;274(31):21569–74. doi: 10.1074/jbc.274.31.21569. PMID: 10419462.; Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, Sarau HM. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature. 1999 Jul 15;400(6741):261–5. doi: 10.1038/22313. PMID: 10421367.; Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature. 1999 Jul 15;400(6741):265–9. doi: 10.1038/22321. PMID: 10421368.; Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S. [Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers]. Nippon Ganka Gakkai Zasshi. 1999 Jul;103(7):544–50. PMID: 10443129.; Toris CB, Camras CB, Yablonski ME. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American Journal of Ophthalmology. 1999 Jul;128(1):8–14. doi: 10.1016/s0002-9394(99)00076-8.; Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, Nargund R, Bakshi R, Abramovitz M, Stocco R, Kargman S, O'Neill G, Van Der Ploeg LH, Evans J, Patchett AA, Smith RG, Howard AD. Receptor for motilin identified in the human gastrointestinal system. Science. 1999 Jun 25;284(5423):2184–8. doi: 10.1126/science.284.5423.2184. PMID: 10381885.; Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, Goto K. Structure and Function of Human Prepro-orexin Gene. Journal of Biological Chemistry. 1999 Jun;274(25):17771–6. doi: 10.1074/jbc.274.25.17771.; Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). The Lancet. 1999 Jun;353(9169):2001–7. doi: 10.1016/s0140-6736(99)04440-2.; Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG. Cloning and Functional Expression of the Human Histamine H3 Receptor. Molecular Pharmacology. 1999 Jun;55(6):1101–7. doi: 10.1016/s0026-895x(24)23263-6.; Taniguchi T, Inagaki R, Murata S, Akiba I, Muramatsu I. Microphysiometric analysis of human a _1a -adrenoceptor expressed in Chinese hamster ovary cells. British J Pharmacology. 1999 Jun;127(4):962–8. doi: 10.1038/sj.bjp.0702609.; Zaballos A, Gutie´rrez J, Varona R, Ardavi´n C, Ma´rquez G. Cutting Edge: Identification of the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the Chemokine TECK. 1999 May 15;162(10):5671–5. doi: 10.4049/jimmunol.162.10.5671.; Russell FD, Davenport AP. Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res. 1999 Apr 30;84(8):891–6. doi: 10.1161/01.res.84.8.891. PMID: 10222335.; Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999 Mar;103(6):879–87. PMID: 10079109; PMCID: PMC408153.; Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, Coulombe N, Tan CP, Tang-Nguyen AT, George SR, O'Dowd BF. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999 Mar 05;446(1):103–7. doi: 10.1016/s0014-5793(99)00009-5. PMID: 10100623.; Gessi S, Campi F, Varani K, Borea PA. Alpha2-adrenergic agonist modulation of [35S]GTPgammaS binding to guanine-nucleotide-binding-proteins in human platelet membranes. Life Sci. 1999;64(16):1403–13. doi: 10.1016/s0024-3205(99)00074-0. PMID: 10321720.; Anderson JL, Prystowsky EN. Sotalol: An important new antiarrhythmic. Am Heart J. 1999 Mar;137(3):388–409. doi: 10.1016/s0002-8703(99)70484-9. PMID: 10047618.; Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999 Feb;54(2):146–65. doi: 10.1046/j.1365-2044.1999.00659.x. PMID: 10215710.; Sega R. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group. Blood Press. 1999;8(2):114–21. doi: 10.1080/080370599438293. PMID: 10451039.; Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. British J Pharmacology. 1998 Dec;125(7):1463–70. doi: 10.1038/sj.bjp.0702220.; Kolakowski LF, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD, Sawzdargo M, Nguyen T, Kargman S, Shiao LL, Hreniuk DL, Tan CP, Evans J, Abramovitz M, Chateauneuf A, Coulombe N, Ng G, Johnson MP, Tharian A, Khoshbouei H, George SR, Smith RG, O'Dowd BF. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem. 1998 Dec;71(6):2239–51. doi: 10.1046/j.1471-4159.1998.71062239.x. PMID: 9832121.; Francken BJB, Jurzak M, Vanhauwe JFM, Luyten WHML, Leysen JE. The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. European Journal of Pharmacology. 1998 Nov;361(2-3):299–309. doi: 10.1016/s0014-2999(98)00744-4.; Vita N, Oury-Donat F, Chalon P, Guillemot M, Kaghad M, Bachy A, Thurneyssen O, Garcia S, Poinot-Chazel C, Casellas P, Keane P, Le Fur G, Maffrand JP, Soubrie P, Caput D, Ferrara P. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur J Pharmacol. 1998 Nov 06;360(2-3):265–72. doi: 10.1016/s0014-2999(98)00678-5. PMID: 9851594.; Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou M, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor. Biochemical and Biophysical Research Communications. 1998 Oct;251(2):471–6. doi: 10.1006/bbrc.1998.9489.; Smith KE, Walker MW, Artymyshyn R, Bard J, Borowsky B, Tamm JA, Yao WJ, Vaysse PJ, Branchek TA, Gerald C, Jones KA. Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem. 1998 Sep 04;273(36):23321–6. doi: 10.1074/jbc.273.36.23321. PMID: 9722565.; Fathi Z, Battaglino PM, Iben LG, Li H, Baker E, Zhang D, McGovern R, Mahle CD, Sutherland GR, Iismaa TP, Dickinson KE, Zimanyi IA. Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor. Brain Res Mol Brain Res. 1998 Jul 15;58(1-2):156–69. doi: 10.1016/s0169-328x(98)00116-8. PMID: 9685625.; Albright JD, Reich MF, Delos Santos EG, Dusza JP, Sum F, Venkatesan AM, Coupet J, Chan PS, Ru X, Mazandarani H, Bailey T. 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors. J. Med. Chem. 1998 Jun 16;41(14):2442–4. doi: 10.1021/jm980179c.; Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998 Jun 15;187(12):2009–21. PMID: 9625760; PMCID: PMC2212354.; Dealwis C, Fernandez EJ, Thompson DA, Simon RJ, Siani MA, Lolis E. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 'fusin' coreceptor. Proc Natl Acad Sci U S A. 1998 Jun 09;95(12):6941–6. PMID: 9618518; PMCID: PMC22694.; Caulfield MP, Birdsall NJM. International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors. Pharmacological Reviews. 1998 Jun;50(2):279–90. doi: 10.1016/s0031-6997(24)01362-0.; Russo D, Redman C, Lee S. Association of XK and Kell Blood Group Proteins. Journal of Biological Chemistry. 1998 May;273(22):13950–6. doi: 10.1074/jbc.273.22.13950.; Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain. Nature. 1998 May 21;393(6682):272–6. doi: 10.1038/30515. PMID: 9607765.; Jasper JR, Lesnick JD, Chang LK, Yamanishi SS, Chang TK, Hsu SA, Daunt DA, Bonhaus DW, Eglen RM. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol. 1998 Apr 01;55(7):1035–43. doi: 10.1016/s0006-2952(97)00631-x. PMID: 9605427.; Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7. Journal of Biological Chemistry. 1998 Mar;273(12):7118–22. doi: 10.1074/jbc.273.12.7118.; Okuda-Ashitaka E, Minami T, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 1998 Mar 19;392(6673):286–9. doi: 10.1038/32660. PMID: 9521323.; Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998 Mar 06;92(5):1 page following 696. doi: 10.1016/s0092-8674(02)09256-5. PMID: 9527442.; Dong Z, Wang X, Zhao Q, Townsend CM, Evers BM. DNA methylation contributes to expression of the human neurotensin/neuromedin N gene. American Journal of Physiology-Gastrointestinal and Liver Physiology. 1998 Mar 01;274(3):G535–43. doi: 10.1152/ajpgi.1998.274.3.g535.; Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998 Feb 16;187(4):655–60. PMID: 9463416; PMCID: PMC2212150.; Goya I, Gutie´rrez J, Varona R, Kremer L, Zaballos A, Ma´rquez G. Identification of CCR8 as the Specific Receptor for the Human ß-Chemokine I-309: Cloning and Molecular Characterization of Murine CCR8 as the Receptor for TCA-3. 1998 Feb 15;160(4):1975–81. doi: 10.4049/jimmunol.160.4.1975.; Day R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, Lindberg I. Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J Biol Chem. 1998 Jan 09;273(2):829–36. doi: 10.1074/jbc.273.2.829. PMID: 9422738.; McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics. 1997 Dec 15;46(3):426–34. doi: 10.1006/geno.1997.5069. PMID: 9441746.; Schweizer A, Valdenaire O, Nelböck P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Löffler BM. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J. 1997 Dec 15;328 ( Pt 3)():871–7. PMID: 9396733; PMCID: PMC1218999.; Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63–9. doi: 10.1007/pl00005139. PMID: 9459574.; Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997 Nov 14;91(4):521–30. doi: 10.1016/s0092-8674(00)80438-9. PMID: 9390561.; Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 1997 Sep 01;100(5):1137–43. PMID: 9276730; PMCID: PMC508288.; Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. International Union of Pharmacology. XIII. Classification of Histamine Receptors. Pharmacological Reviews. 1997 Sep;49(3):253–78. doi: 10.1016/s0031-6997(24)01328-0.; Black H, Graff A, Shute D, Stoltz R, Ruff D, Levine J, Shi Y, Mallows S. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. Journal of Human Hypertension. 1997 Aug 01;11(8):483–9. doi: 10.1038/sj.jhh.1000482.; Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, Moser B. Identification of CCR8, the Receptor for the Human CC Chemokine I-309. Journal of Biological Chemistry. 1997 Jul;272(28):17251–4. doi: 10.1074/jbc.272.28.17251.; Tiffany HL, Lautens LL, Gao JL, Pease J, Locati M, Combadiere C, Modi W, Bonner TI, Murphy PM. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med. 1997 Jul 07;186(1):165–70. PMID: 9207005; PMCID: PMC2198957.; Perry SJ, Yi-Kung Huang E, Cronk D, Bagust J, Sharma R, Walker RJ, Wilson S, Burke JF. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 1997 Jun 16;409(3):426–30. doi: 10.1016/s0014-5793(97)00557-7. PMID: 9224703.; Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama H, Yoshie O. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC. Journal of Biological Chemistry. 1997 Jun;272(23):14893–8. doi: 10.1074/jbc.272.23.14893.; Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med. 1997 Jun 02;185(11):2015–23. PMID: 9166430; PMCID: PMC2196334.; Rovai LE, Herschman HR, Smith JB. Cloning and characterization of the human granulocyte chemotactic protein-2 gene. 1997 Jun 01;158(11):5257–66. doi: 10.4049/jimmunol.158.11.5257.; Saito M, Tahara A, Sugimoto T. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. Biochem Pharmacol. 1997 Jun 01;53(11):1711–7. doi: 10.1016/s0006-2952(97)00070-1. PMID: 9264324.; Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent J, Checler F. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. British J Pharmacology. 1997 Jun;121(4):705–10. doi: 10.1038/sj.bjp.0701182.; Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O. Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7. Journal of Biological Chemistry. 1997 May;272(21):13803–9. doi: 10.1074/jbc.272.21.13803.; Wu C, Chan MF, Stavros F, Raju B, Okun I, Mong S, Keller KM, Brock T, Kogan TP, Dixon RA. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J Med Chem. 1997 May 23;40(11):1690–7. doi: 10.1021/jm9700068. PMID: 9171878.; Leung M, Grunwald JE. Short-term effects of topical levobunolol on the human retinal circulation. Eye (Lond). 1997;11 ( Pt 3)():371–6. doi: 10.1038/eye.1997.78. PMID: 9373479.; Hagmann M, Nussberger J, Naudin RB, Burns TS, Karim A, Waeber B, Brunner HR. SC-52458, an Orally Active Angiotensin II-Receptor Antagonist: Inhibition of Blood Pressure Response to Angiotensin II Challenges and Pharmacokinetics in Normal Volunteers. Journal of Cardiovascular Pharmacology. 1997 Apr;29(4):444–50. doi: 10.1097/00005344-199704000-00003.; Feng Y, Gregor P. Cloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide Receptors. Biochemical and Biophysical Research Communications. 1997 Feb;231(3):651–4. doi: 10.1006/bbrc.1997.6161.; Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997 Feb 13;385(6617):640–4. doi: 10.1038/385640a0. PMID: 9024663.; Yoshida T, Imai T, Takagi S, Nishimura M, Ishikawa I, Yaoi T, Yoshie O. Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett. 1996 Oct 14;395(1):82–8. doi: 10.1016/0014-5793(96)01004-6. PMID: 8849694.; Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996 Sep 01;184(3):963–9. PMID: 9064356; PMCID: PMC2192763.; Weber C, Schmitt R, Birnboeck H, Hopfgartner G, Marle SP, Peeters PAM, Jonkman JHG, Jones C. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clinical Pharmacology & Therapeutics. 1996 Aug 23;60(2):124–37. doi: 10.1016/s0009-9236(96)90127-7.; Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C, Zeng Z, Su K, Jurewicz AJ, Hertzberg RP, Bergsma DJ, Kumar C. Molecular Cloning and Characterization of the Human Anaphylatoxin C3a Receptor. Journal of Biological Chemistry. 1996 Aug;271(34):20231–4. doi: 10.1074/jbc.271.34.20231.; Mollereau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier JC, Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. U.S.A. 1996 Aug 06;93(16):8666–70. doi: 10.1073/pnas.93.16.8666.; Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, Bunnett NW. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J. 1996 Mar 15;314 ( Pt 3)():1009–16. PMID: 8615752; PMCID: PMC1217107.; Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DE, Padley RJ. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group. Urology. 1996 Feb;47(2):159–68. doi: 10.1016/s0090-4295(99)80409-9. PMID: 8607227.; Bräuner-Osborne H, Brann MR. Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells. Eur J Pharmacol. 1996 Jan 04;295(1):93–102. doi: 10.1016/0014-2999(95)00639-7. PMID: 8925880.; Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 1996 Mar 19;35(11):3362–7. doi: 10.1021/bi952950g. PMID: 8639485.; Mallion JM, Goldberg AI. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Blood Press Suppl. 1996;2():82–6. PMID: 8913546.; Gerald C, Walker MW, Vaysse PJ-, He C, Branchek TA, Weinshank RL. Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor Subtype. Journal of Biological Chemistry. 1995 Nov;270(45):26758–61. doi: 10.1074/jbc.270.45.26758.; Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY. Journal of Biological Chemistry. 1995 Nov;270(45):26762–5. doi: 10.1074/jbc.270.45.26762.; Dauch P, Vincent J, Checler F. Molecular Cloning and Expression of Rat Brain Endopeptidase 3.4.24.16. Journal of Biological Chemistry. 1995 Nov;270(45):27266–71. doi: 10.1074/jbc.270.45.27266.; Kaplan SA, Meade-D'Alisera P, Quiñones S, Soldo KA. Doxazosin in physiologically and pharmacologically normotensive men with benign prostatic hyperplasia. Urology. 1995 Oct;46(4):512–7. doi: 10.1016/s0090-4295(99)80264-7. PMID: 7571220.; MARCHESE A, HEIBER M, NGUYEN T, HENG HHQ, SALDIVIA VR, CHENG R, MURPHY PM, TSUI L, SHI X, GREGOR P, GEORGE SR, O'DOWD BF, DOCHERTY JM. Cloning and Chromosomal Mapping of Three Novel Genes, GPR9, GPR10, and GPR14, Encoding Receptors Related to Interleukin 8, Neuropeptide Y, and Somatostatin Receptors. Genomics. 1995 Sep;29(2):335–44. doi: 10.1006/geno.1995.9996.; Hone K, Obika K, Foglar R, Tsujimoto G. Selectivity of the imidazoline a-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned a₁-adrenoceptor subtypes. British J Pharmacology. 1995 Sep;116(1):1611–8. doi: 10.1111/j.1476-5381.1995.tb16381.x.; Krempl GA, Noorily AD. Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol. 1995 Sep;104(9 Pt 1):704–6. doi: 10.1177/000348949510400906. PMID: 7661519.; Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AEI, Wells TNC. Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line. Journal of Biological Chemistry. 1995 Aug;270(33):19495–500. doi: 10.1074/jbc.270.33.19495.; Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 1995 Aug 10;28(3):495–500. doi: 10.1006/geno.1995.1180. PMID: 7490086.; Simonin F, Gavériaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattéi MG, Charron G, Bloch B, Kieffer B. kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 1995 Jul 18;92(15):7006–10. doi: 10.1073/pnas.92.15.7006.; Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. Journal of Biological Chemistry. 1995 Dec;270(50):30235. doi: 10.1016/s0021-9258(17)45856-x.; Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A. Molecular cloning and functional characterization of human lymphotactin. 1995 Jul 01;155(1):203–9. doi: 10.4049/jimmunol.155.1.203.; O'Dowd BF, Scheideler MA, Nguyen T, Cheng R, Rasmussen JS, Marchese A, Zastawny R, Heng HHQ, Tsui L, Shi X, Asa S, Puy L, George SR. The Cloning and Chromosomal Mapping of Two Novel Human Opioid-Somatostatin-like Receptor Genes, GPR7 and GPR8, Expressed in Discrete Areas of the Brain. Genomics. 1995 Jul;28(1):84–91. doi: 10.1006/geno.1995.1109.; Emoto N, Yanagisawa M. Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH Optimum. Journal of Biological Chemistry. 1995 Jun;270(25):15262–8. doi: 10.1074/jbc.270.25.15262.; Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP, Murphy TJ. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Molecular Pharmacology. 1995 May;47(5):977–85. doi: 10.1016/s0026-895x(25)08607-9.; Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. The American Journal of Cardiology. 1995 Apr;75(12):793–5. doi: 10.1016/s0002-9149(99)80413-5.; Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll A, Patel YC, Schonbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin receptors. Trends in Pharmacological Sciences. 1995 Mar;16(3):86–8. doi: 10.1016/s0165-6147(00)88988-9.; Yoshida T, Imai T, Kakizaki M, Nishimura M, Yoshie O. Molecular cloning of a novel C or gamma type chemokine, SCM-1. FEBS Lett. 1995 Feb 27;360(2):155–9. doi: 10.1016/0014-5793(95)00093-o. PMID: 7875320.; Bossmar T, Åkerlund M, Fantoni G, Szamatowicz J, Melin P, Maggi M. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: Effects of the oxytocin antagonist atosiban. American Journal of Obstetrics and Gynecology. 1994 Dec;171(6):1634–42. doi: 10.1016/0002-9378(94)90415-4.; Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. Journal of Biological Chemistry. 1994 Oct;269(43):27088–92. doi: 10.1016/s0021-9258(18)47129-3.; Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc. Natl. Acad. Sci. U.S.A. 1994 Oct 11;91(21):9780–3. doi: 10.1073/pnas.91.21.9780.; Schweickart VL, Raport CJ, Godiska R, Byers MG, Eddy RL, Shows TB, Gray PW. Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. Genomics. 1994 Oct;23(3):643–50. doi: 10.1006/geno.1994.1553. PMID: 7851893.; Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, Hess JF. Expression cloning of a human B1 bradykinin receptor. Journal of Biological Chemistry. 1994 Aug;269(34):21583–6. doi: 10.1016/s0021-9258(17)31844-6.; Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994 Aug 12;78(3):473–85. doi: 10.1016/0092-8674(94)90425-1. PMID: 8062389.; Guthrie R. Terazosin in the treatment of hypertension and symptomatic benign prostatic hyperplasia: a primary care trial. J Fam Pract. 1994 Aug;39(2):129–33. PMID: 7520053.; Yamagami S, Tokuda Y, Ishii K, Tanaka H, Endo N. cDNA Cloning and Functional Expression of a Human Monocyte Chemoattractant Protein 1 Receptor. Biochemical and Biophysical Research Communications. 1994 Jul;202(2):1156–62. doi: 10.1006/bbrc.1994.2049.; Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med. 1994 Jul 01;180(1):253–60. PMID: 8006586; PMCID: PMC2191537.; Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 1994 Jul;270(1):228–35. doi: 10.1016/s0022-3565(25)22357-6.; Tsuzuki S, Ichiki T, Nakakubo H, Kitami Y, Guo DF, Shirai H, Inagami T. Molecular Cloning and Expression of the Gene Encoding Human Angiotensin II Type 2 Receptor. Biochemical and Biophysical Research Communications. 1994 May;200(3):1449–54. doi: 10.1006/bbrc.1994.1613.; Itskovitz HD. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Clin Ther. 1994 May;16(3):490–504. PMID: 7923316.; Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 1994 Mar 14;341(1):33–8. doi: 10.1016/0014-5793(94)80235-1. PMID: 8137918.; Noyer M, de Laveleye F, Vauquelin G, Gobert J, Wülfert E. Mivazerol, a novel compound with high specificity for alpha 2 adrenergic receptors: binding studies on different human and rat membrane preparations. Neurochem Int. 1994 Mar;24(3):221–9. doi: 10.1016/0197-0186(94)90079-5. PMID: 8025531.; Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. Journal of Biological Chemistry. 1994 Feb;269(5):3304–10. doi: 10.1016/s0021-9258(17)41863-1.; Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 1994 Jan 31;338(2):217–22. doi: 10.1016/0014-5793(94)80368-4. PMID: 7905839.; Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, Yamamura HI. Identification of a human delta opioid receptor: Cloning and expression. Life Sciences. 1994 Jan;54(25):PL463–9. doi: 10.1016/0024-3205(94)90138-4.; Debacker MD, Gommeren W, Moereels H, Nobels G, Vangompel P, Leysen JE, Luyten WHML. Genomic Cloning, Heterologous Expression and Pharmacological Characterization of a Human Histamine H1 Receptor. Biochemical and Biophysical Research Communications. 1993 Dec;197(3):1601–8. doi: 10.1006/bbrc.1993.2662.; O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR, Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993 Dec 22;136(1-2):355–60. doi: 10.1016/0378-1119(93)90495-o. PMID: 8294032.; Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO. Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc. Natl. Acad. Sci. U.S.A. 1993 Nov 15;90(22):10793–7. doi: 10.1073/pnas.90.22.10793.; Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy. 1993 Nov;13(6 Pt 2):110S–115S; discussion 143S. PMID: 7507588.; Suzuki T, Nantel F, Bonin H, Valiquette M, Bouvier M. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 1993 Nov;267(2):785–90. doi: 10.1016/s0022-3565(25)39380-8.; Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y. Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor Subtype. Biochemical and Biophysical Research Communications. 1993 Sep;195(2):844–52. doi: 10.1006/bbrc.1993.2122.; Hirasawa A, Horie K, Tanaka T, Takagaki K, Murai M, Yano J, Tsujimoto G. Cloning, Functional Expression and Tissue Distribution of Human cDNA for the a1C-Adrenergic Receptor. Biochemical and Biophysical Research Communications. 1993 Sep;195(2):902–9. doi: 10.1006/bbrc.1993.2130.; Matre V, Karlsen HE, Wright MS, Lundell I, Fjeldheim AK, Gabrielsen OS, Larhammar D, Gautvik KM. Molecular Cloning of a Functional Human Thyrotropin-Releasing Hormone Receptor. Biochemical and Biophysical Research Communications. 1993 Aug;195(1):179–85. doi: 10.1006/bbrc.1993.2027.; Herzog H, Hort YJ, Shine J, Selbie LA. Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell Biol. 1993 Jul;12(6):465–71. doi: 10.1089/dna.1993.12.465. PMID: 8329116.; Ulrich CD, Ferber I, Holicky E, Hadac E, Buell G, Miller LJ. Molecular Cloning and Functional Expression of the Human Gallbladder Cholecystokinin A Receptor. Biochemical and Biophysical Research Communications. 1993 May;193(1):204–11. doi: 10.1006/bbrc.1993.1610.; Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T. Molecular cloning of a novel melanocortin receptor. Journal of Biological Chemistry. 1993 Apr;268(11):8246–50. doi: 10.1016/s0021-9258(18)53088-x.; Farber JM. HuMig: A New Human Member of the Chemokine Family of Cytokines. Biochemical and Biophysical Research Communications. 1993 Apr;192(1):223–30. doi: 10.1006/bbrc.1993.1403.; Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol. 1993 Apr;67(4):2209–20. doi: 10.1128/jvi.67.4.2209-2220.1993.; Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA, Battey JF. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. Journal of Biological Chemistry. 1993 Mar;268(8):5979–84. doi: 10.1016/s0021-9258(18)53415-3.; Shamburek RD, Schubert ML. Pharmacology of gastric acid inhibition. Baillieres Clin Gastroenterol. 1993 Mar;7(1):23–54. doi: 10.1016/0950-3528(93)90030-v. PMID: 8097411.; Elshourbagy NA, Korman DR, Wu HL, Sylvester DR, Lee JA, Nuthalaganti P, Bergsma DJ, Kumar CS, Nambi P. Molecular characterization and regulation of the human endothelin receptors. Journal of Biological Chemistry. 1993 Feb;268(6):3873–9. doi: 10.1016/s0021-9258(18)53554-7.; Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell. 1993 Feb 12;72(3):415–25. doi: 10.1016/0092-8674(93)90118-a. PMID: 7679328.; Vita N, Laurent P, Lefort S, Chalon P, Dumont X, Kaghad M, Gully D, Le Fur G, Ferrara P, Caput D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 1993 Feb 08;317(1-2):139–42. doi: 10.1016/0014-5793(93)81509-x. PMID: 8381365.; Adham N, Kao HT, Schecter LE, Bard J, Olsen M, Urquhart D, Durkin M, Hartig PR, Weinshank RL, Branchek TA. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 1993 Jan 15;90(2):408–12. doi: 10.1073/pnas.90.2.408.; Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI, Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol. 1992 Dec;6(12):2136–42. doi: 10.1210/mend.6.12.1337145. PMID: 1337145.; Pisegna JR, Weerth AD, Huppi K, Wank SA. Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization. Biochemical and Biophysical Research Communications. 1992 Nov;189(1):296–303. doi: 10.1016/0006-291x(92)91557-7.; Ramarao CS, Denker JM, Perez DM, Gaivin RJ, Riek RP, Graham RM. Genomic organization and expression of the human alpha 1B-adrenergic receptor. Journal of Biological Chemistry. 1992 Oct;267(30):21936–45. doi: 10.1016/s0021-9258(19)36703-1.; Stam NJ, Van Huizen F, Van Alebeek C, Dijkema R, Tonnaer JADM, Olijve W. Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. European Journal of Pharmacology: Molecular Pharmacology. 1992 Oct;227(2):153–62. doi: 10.1016/0922-4106(92)90123-d.; Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992 Aug 28;257(5074):1248–51. doi: 10.1126/science.1325670. PMID: 1325670.; Zgombick JM, Schechter LE, Macchi M, Hartig PR, Branchek TA, Weinshank RL. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor. Molecular Pharmacology. 1992 Aug;42(2):180–5. doi: 10.1016/s0026-895x(25)08894-7.; Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. Journal of Biological Chemistry. 1992 Jun;267(16):10935–8. doi: 10.1016/s0021-9258(19)49854-2.; Hamblin MW, Metcalf MA, McGuffin RW, Karpells S. Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: A homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Biochemical and Biophysical Research Communications. 1992 Apr;184(2):752–9. doi: 10.1016/0006-291x(92)90654-4.; Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochemical and Biophysical Research Communications. 1992 Apr;184(2):582–9. doi: 10.1016/0006-291x(92)90629-y.; Huang RC, Cheung AH, Mazina KE, Strader CD, Fong TM. cDNA Sequence and heterologous expression of the human neurokinin-3 receptor. Biochemical and Biophysical Research Communications. 1992 Apr;184(2):966–72. doi: 10.1016/0006-291x(92)90685-e.; Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochemical and Biophysical Research Communications. 1992 Apr;184(1):260–8. doi: 10.1016/0006-291x(92)91187-u.; Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA, Hartig PR. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. Proc. Natl. Acad. Sci. U.S.A. 1992 Apr 15;89(8):3630–4. doi: 10.1073/pnas.89.8.3630.; Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature. 1992 Apr 09;356(6369):526–9. doi: 10.1038/356526a0. PMID: 1313946.; Bergsma DJ, Ellis C, Kumar C, Nuthulaganti P, Kersten H, Elshourbagy N, Griffin E, Stadel JM, Aiyar N. Cloning and characterization of a human angiotensin II type 1 receptor. Biochemical and Biophysical Research Communications. 1992 Mar;183(3):989–95. doi: 10.1016/s0006-291x(05)80288-8.; Bolden C, Cusack B, Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. The Journal of Pharmacology and Experimental Therapeutics. 1992 Feb;260(2):576–80. doi: 10.1016/s0022-3565(25)11335-9.; Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A. 1992 Jan 01;89(1):251–5. PMID: 1346068; PMCID: PMC48214.; Cocco G, Alfiero R, Pouleur H. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure. Clin Cardiol. 1992 Jan;15(1):38–42. doi: 10.1002/clc.4960150109. PMID: 1347258.; Schmidt WE, Kratzin H, Eckart K, Drevs D, Mundkowski G, Clemens A, Katsoulis S, Schäfer H, Gallwitz B, Creutzfeldt W. Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide. Proc. Natl. Acad. Sci. U.S.A. 1991 Dec 15;88(24):11435–9. doi: 10.1073/pnas.88.24.11435.; Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med. 1991 Dec 01;174(6):1355–62. PMID: 1744577; PMCID: PMC2119025.; Adachi M, Yang Y, Furuichi Y, Miyamoto C. Cloning and characterization of cDNA encoding human a-type endothelin receptor. Biochemical and Biophysical Research Communications. 1991 Nov;180(3):1265–72. doi: 10.1016/s0006-291x(05)81332-4.; Pauwels PJ, Van Gompel P, Leysen JE. Human beta 1- and beta 2-adrenergic receptor binding and mediated accumulation of cAMP in transfected Chinese hamster ovary cells. Profile of nebivolol and known beta-adrenergic blockers. Biochem Pharmacol. 1991 Oct 09;42(9):1683–9. doi: 10.1016/0006-2952(91)90502-v. PMID: 1681809.; Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA, Battey JF. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. Journal of Biological Chemistry. 1991 Oct;266(28):18771–9. doi: 10.1016/s0021-9258(18)55129-2.; Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE. Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochemical and Biophysical Research Communications. 1991 Sep;179(3):1232–40. doi: 10.1016/0006-291x(91)91704-g.; Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science. 1991 Sep 13;253(5025):1278–80. doi: 10.1126/science.1840701. PMID: 1840701.; Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 1991 Sep 13;253(5025):1280–3. doi: 10.1126/science.1891716. PMID: 1891716.; Gantz I, Munzert G, Tashiro T, Schäffer M, Wang L, DelValle J, Yamada T. Molecular cloning of the human histamine H2 receptor. Biochemical and Biophysical Research Communications. 1991 Aug;178(3):1386–92. doi: 10.1016/0006-291x(91)91047-g.; Bersani M, Johnsen AH, Højrup P, Dunning BE, Andreasen JJ, Holst JJ. Human galanin: primary structure and identification of two molecular forms. FEBS Lett. 1991 Jun 03;283(2):189–94. doi: 10.1016/0014-5793(91)80585-q. PMID: 1710578.; Nakamuta M, Takayanagi R, Sakai Y, Sakamoto S, Hagiwara H, Mizuno T, Saito Y, Hirose S, Yamamoto M, Nawata H. Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochemical and Biophysical Research Communications. 1991 May;177(1):34–9. doi: 10.1016/0006-291x(91)91944-8.; Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB. Cloning of the gene for a human dopamine D5 receptor